Both in Pharmaceuticals
Biomea Fusion vs Actinium Pharmaceuticals
Over the past year BMEA returned −51.1% and ATNM returned +6.5%; their daily moves had a correlation of 0.03.
BMEA −51.1% ATNM +6.5%Growth of $1, one year, split-adjusted
| Metric | BMEA | ATNM |
|---|---|---|
| Price | $0.6450 | $1.47 |
| Market cap | $46.7M | $46.2M |
| Today | +0.85% | −0.68% |
| 1 month | −49.2% | +25.6% |
| 6 months | −56.4% | +22.5% |
| Year to date | −48.0% | +8.1% |
| 1 year | −51.5% | +3.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | 79.7% |
| P/E (TTM) | — | 4.1× |
| Price / sales | — | 1.3× |
| Net cash | $34.8M | $36.5M |
| Dividend yield | — | — |
| Volatility (60d) | 121.6% | 90.4% |
| Short % of float | 24.1% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).